| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | US20030068652 Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searching |
| 04/10/2003 | US20030068641 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 04/10/2003 | US20030068325 A peptide immunogen of about 20 to 100 amino acids long comprising: a helper T cell (Th) epitope, an N-terminal fragment of A beta 1-42 peptide, consisting from 10-28 amino acid residues |
| 04/10/2003 | CA2462796A1 Gene regulatory peptides |
| 04/10/2003 | CA2462443A1 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/09/2003 | EP1300418A1 Gene regulation by oligopeptides |
| 04/09/2003 | EP1300416A1 Memory-enhancing peptides and the use thereof |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299411A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 04/09/2003 | EP1189933B1 Echinocandin derivatives, method for preparing the same and application as antifungal agents |
| 04/09/2003 | EP0998494B1 Pompilid wasp-derived neuropeptides |
| 04/09/2003 | EP0779933B1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 04/09/2003 | CN1409725A Peptide minics of conserved gonococcal epitopes and methods and compositions using them |
| 04/08/2003 | US6545162 Solid phase biosynthesis of viricide antibiotic |
| 04/08/2003 | US6545125 Reaction product containing paclitaxel; anticancer agent |
| 04/08/2003 | US6545123 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/08/2003 | US6544950 For therapy of cerebral ischemia and ischemic heart disease including reperfusion injury |
| 04/08/2003 | US6544750 Prevent thrombosis |
| 04/08/2003 | US6544728 Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 |
| 04/08/2003 | US6544520 Isolated, purified peptide that inhibits hepatitis B virus assembly by binding to the core antigen of hepatitis B virus and preventing association |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | CA2109830C Lhrh antagonists and intermediate products |
| 04/08/2003 | CA2074322C A composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/03/2003 | WO2003027255A2 Anti-fusion assay |
| 04/03/2003 | WO2003027246A2 Antagonists |
| 04/03/2003 | WO2003027122A2 Lanthanide binding tags |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003026590A2 Biological control of nanoparticles |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/03/2003 | US20030066095 Wherein linkage between proteins (aequorin and green fluorescent protein (GFP)) stabilizes the system and allow energy transfer via chemiluminescence resonance energy transfer |
| 04/03/2003 | US20030065151 Secreted protein HCEJQ69 |
| 04/03/2003 | US20030065136 Cyclic peptide for use in the treatment of inflammatory and autoimmune disease |
| 04/03/2003 | US20030064984 Anticancer agents; side effect reduction |
| 04/03/2003 | US20030064918 Administering amylin; osteoporosis |
| 04/03/2003 | US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/03/2003 | US20030064077 Recombinant poxvirus cytomegalovirus, compositions, and uses |
| 04/03/2003 | CA2461898A1 Biological control of nanoparticles |
| 04/03/2003 | CA2461853A1 Anti-fusion assay |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2459999A1 Antagonists_and agonists of igf-1 receptor |
| 04/02/2003 | EP1298142A1 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 04/02/2003 | EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 04/02/2003 | EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 04/02/2003 | EP1297001A1 Amphipathic linear peptides and compositions containing same |
| 04/02/2003 | EP1297000A2 Peptides mimicking the biological activity of steroid hormones and their uses |
| 04/02/2003 | EP1296999A2 Neuroactive peptides for treatment of hypoxia and related conditions |
| 04/02/2003 | EP1296718A1 Pharmaceutical composition of modified pna molecules |
| 04/02/2003 | EP1296702A1 Neuroprotective peptides |
| 04/02/2003 | EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 04/02/2003 | EP0871464B1 Bradykinin analogs as selective thrombin inhibitors |
| 04/02/2003 | EP0728208B1 Tomato xyloglucan endo-transglycosylase |
| 04/02/2003 | EP0644772B1 Opioid peptides |
| 04/02/2003 | CN1406948A Peptide as VEGF receptor KDR antagonist |
| 04/02/2003 | CN1406947A Short peptide and its derivative and medicine with them as active component and use thereof |
| 04/02/2003 | CN1104256C Cyclosporin soft capsule composition |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541453 Peptide derivatives |
| 04/01/2003 | US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 04/01/2003 | US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease |
| 04/01/2003 | US6541002 Rendering a polypeptide capable of binding with virion by altering the polypeptide such that the altered polypeptide comprises a Vpr-binding region having specific amino acid sequence |
| 04/01/2003 | US6540893 Ion sensor |
| 03/27/2003 | WO2003025121A2 Igf-binding protein-derived peptide or small molecule |
| 03/27/2003 | WO2003025012A2 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 03/27/2003 | WO2003025011A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/27/2003 | WO2003025001A1 Multiple antigen peptides (map) as antidotes against snake neurotoxin intoxication |
| 03/27/2003 | WO2003024996A2 Antibacterial macrocycles |
| 03/27/2003 | WO2003024477A1 Method for delivery of molecules to intracellular targets |
| 03/27/2003 | WO2002078607A3 Mucin peptide with immunoenhancing properties |
| 03/27/2003 | WO2002056829A3 Methods for preparing purified daptomycin |
| 03/27/2003 | WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 03/27/2003 | WO2002048157A3 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors |
| 03/27/2003 | WO2001061346A3 Methods for identifying agents causing a lethal phenotype |
| 03/27/2003 | US20030060613 Protein for use in the treatment of bone, tumor and inflammatory disorders |
| 03/27/2003 | US20030060598 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 03/27/2003 | US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction |
| 03/27/2003 | US20030059906 Block copolymers for multifunctional self-assembled systems |
| 03/27/2003 | US20030059836 Rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 03/27/2003 | US20030059767 Zinc finger protein derivatives and methods therefor |
| 03/27/2003 | US20030059765 Compositions and methods for providing a protein to a virion |
| 03/27/2003 | US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets |
| 03/27/2003 | US20030059430 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/27/2003 | US20030059422 Tuftsin metallopeptide analogs and uses thereof |
| 03/27/2003 | CA2460719A1 Igf-binding protein-derived peptide or small molecule |
| 03/27/2003 | CA2460646A1 Antibacterial macrocycles |
| 03/27/2003 | CA2460048A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294928A1 Screening method for modulators of suv39h2-methyltransferase |
| 03/26/2003 | EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 03/26/2003 | EP1294751A1 Dermacentor variabilis gaba-gated chloride channels |
| 03/26/2003 | EP1294747A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/26/2003 | EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/26/2003 | EP1294745A2 Antimicrobial peptides and methods of use thereof |
| 03/26/2003 | EP1294744A2 Peptides that stimulate cell survival and axon regeneration |
| 03/26/2003 | EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |